These findings echo what we have heard from our own clients. Many of these women continue suffer from alleged transvaginal mesh complications despite having undergone multiple surgeries to remove their implants.
New York, New York (PRWEB) May 20, 2014
As vagina mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/)
continue to mount in courts around the country, Bernstein Liebhard LLP notes that two studies were presented this week at the American Urological Association's annual meeting that suggest many of the injuries alleged in these claims could be permanent, even when a transvaginal mesh implant has been removed. According to HealthDay News, the first study followed 123 women who underwent surgical removal of a transvaginal mesh device or suburethral tape because of chronic pain. Only 67% of the patients who underwent removal of a mesh implant reported being pain free afterwards.*
The second study presented at the meeting surveyed 214 women about three years after they'd had their mesh implants removed due to pain and other complications. At least a third of the women said they continued to suffer moderate-to-severe pain. Twenty-eight percent reported urine leakage at least once a day, while half reported pain during sexual intercourse, according to HealthDay News.
“These findings echo what we have heard from our own clients. Many of these women continue suffer from alleged transvaginal mesh complications despite having undergone multiple surgeries to remove their implants,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free vaginal mesh lawsuit reviews to women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to transvaginal mesh products manufactured by American Medical Systems, Inc., Boston Scientific Corp., C.R. Bard, Inc. and Ethicon, Inc.
Transvaginal Mesh Complications
The U.S. Food & Drug Administration (FDA) has been reviewing the safety of transvaginal mesh used to treat pelvic organ prolapse, as well as stress urinary incontinence, since October 2008, when it first alerted the public to the serious risk of vaginal mesh complications associated with these products. Last month, the agency proposed new rules that, if finalized, would reclassify mesh used to treat prolapse as high-risk medical devices. These products are currently classified as moderate risk.
According The Wall Street Journal, if the FDA’s proposed rules take effect, the devices would no longer be eligible for the agency’s 510(k) clearance process, which allowed transvaginal mesh to be approved without the benefit of human clinical trials. Manufacturers that are currently marketing pelvic mesh for transvaginal prolapse repair would also be required to submit new studies to the FDA demonstrating their safety and effectiveness if they intend to keep selling them.**
According to court documents, more than 50,000 vaginal mesh lawsuits are now pending in several litigations now underway in U.S. District Court, Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committees for several of these procedures, including American Medical Systems, Inc. (MDL No. 2325), Boston Scientific Corp. (MDL No. 2326), C.R. Bard, Inc. (MDL No. 2187) and Ethicon, Inc. (MDL No. 2327).
Mr. Grand has also been appointed Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March with a jury awarding $11 million in compensatory and punitive damages to a woman who was harmed by the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Alleged victims of serious transvaginal mesh complications may be entitled to file their own vaginal mesh lawsuit against the company that manufactured their implant. To learn more about this growing litigation, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*medicalxpress.com/news/2014-05-faulty-mesh-incontinence-women-symptoms.html, HealthDay News, May 19, 2014
**online.wsj.com/article/BT-CO-20140429-719039.html, Wall Street Journal, April 29, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP